{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:35:10Z","timestamp":1787654110342,"version":"build-2736575974"},"reference-count":106,"publisher":"Radcliffe Medical Media Ltd","issue":"1","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arrhythm Electrophysiol Rev"],"published-print":{"date-parts":[[2021,4,12]]},"abstract":"<p>Rhythm and conduction disturbances and sudden cardiac death are important manifestations of cardiac involvement in autoimmune rheumatic diseases (ARD), which have a serious impact on morbidity and mortality. While the underlying arrhythmogenic mechanisms are multifactorial, myocardial fibrosis plays a pivotal role. It accounts for a substantial portion of cardiac mortality and may manifest as atrial and ventricular arrhythmias, conduction system abnormalities, biventricular cardiac failure or sudden death. In patients with ARD, myocardial fibrosis is considered to be the hallmark of cardiac involvement as a result of inflammatory process or to coronary artery occlusive disease. Myocardial fibrosis constitutes the pathological substrates for reentrant circuits. The presence of supraventricular extra systoles, tachyarrhythmias, ventricular activity and conduction disturbances are not uncommon in patients with ARDs, more often in systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, inflammatory muscle disorders and anti-neutrophil cytoplasm antibody-associated vasculitis. In this review, the type, the relative prevalence and the underlying mechanisms of rhythm and conduction disturbances in the emerging field of cardiorheumatology are provided.<\/p>","DOI":"10.15420\/aer.2020.43","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T13:13:44Z","timestamp":1619183624000},"page":"17-25","source":"Crossref","is-referenced-by-count":29,"title":["Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders"],"prefix":"10.15420","volume":"10","author":[{"given":"Sotiris C","family":"Plastiras","sequence":"first","affiliation":[{"name":"Echocardiography Unit, Bioiatriki SA, Bioiatriki Healthcare Group, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M","family":"Moutsopoulos","sequence":"additional","affiliation":[{"name":"Medical Sciences\/Immunology, Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","unstructured":"1. Wahren-Herlenius M, D\u00f6rner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382:819-31.","journal-title":"Lancet"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Seferovi\u0107 PM, Risti\u0107 AD, Maksimovi\u0107 R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006;45:iv39-42.","DOI":"10.1093\/rheumatology\/kel315"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.hrthm.2011.06.032","article-title":"Autoantibodies and cardiac arrhythmias","volume":"8","author":"Lee","year":"2011","unstructured":"3. Lee HC, Huang KT, Wang XL, Shen WK. Autoantibodies and cardiac arrhythmias. Heart Rhythm 2011;8:1788-95.","journal-title":"Heart Rhythm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.05.008","article-title":"Cardiovascular disease in systemic lupus erythematosus: a comprehensive update","volume":"82","author":"Giannelou","year":"2017","unstructured":"4. Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun 2017;82:1-12.","journal-title":"J Autoimmun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaut.2018.05.002","article-title":"B-cell activating factor and related genetic variants in lupus related atherosclerosis","volume":"92","author":"Theodorou","year":"2018","unstructured":"5. Theodorou E, Nezos A, Antypa E, et al. B-cell activating factor and related genetic variants in lupus related atherosclerosis. J Autoimmun 2018;92:87-92.","journal-title":"J Autoimmun"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.autrev.2005.11.002","article-title":"Connective tissue diseases and cardiac rhythm disorders: an overview","volume":"5","author":"Lazzerini","year":"2006","unstructured":"6. Lazzerini PE, Capecchi PL, Guideri F, et al. Connective tissue diseases and cardiac rhythm disorders: an overview. Autoimmun Rev 2006;5:306-13.","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/rheumatology\/kel315","article-title":"Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases","volume":"45","author":"Seferovic","year":"2006","unstructured":"7. Seferovic PM, Ristic AD, Maksimovic R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology 2006;45:39-42.","journal-title":"Rheumatology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1253\/circj.CJ-19-0705","article-title":"Cardiac arrhythmias in autoimmune diseases","volume":"84","author":"Gawa\u0142ko","year":"2020","unstructured":"8. Gawa\u0142ko M, Balsam P, Lodzi\u0144ski P, et al. Cardiac arrhythmias in autoimmune diseases. Circ J 2020;84:685-94.","journal-title":"Circ J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.semarthrit.2008.05.001","article-title":"Arrhythmias and conduction defects in rheumatological diseases-a comprehensive review","volume":"39","author":"Eisen","year":"2009","unstructured":"9. Eisen A, Arnson Y, Dovrish Z, et al. Arrhythmias and conduction defects in rheumatological diseases-a comprehensive review. Semin Arthritis Rheum 2009;39:145-56.","journal-title":"Semin Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/eurheartj\/ehm193","article-title":"Cardiac involvement in systemic inflammatory diseases","volume":"28","author":"Knockaert","year":"2007","unstructured":"10. Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007;28:1797-804.","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Moutsopoulos HM, Zampeli E, eds. Immunology and Rheumatology in Questions. 2nd ed. Cham, Switzerland: Springer Nature, 2021.","DOI":"10.1007\/978-3-030-56670-8"},{"key":"ref11","unstructured":"12. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol 1995;22:1265-70;"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0002-8703(64)90248-0","article-title":"The cardiovascular manifestations of systemic lupus erythemtosus","volume":"68","author":"Hejtmancik","year":"1964","unstructured":"13. Hejtmancik MR, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythemtosus. Am Heart J 1964;68:119-30.","journal-title":"Am Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/00005792-197103000-00001","article-title":"The natural history of systemic lupus erythematosus by prospective analysis","volume":"50","author":"Estes","year":"1971","unstructured":"14. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971;50:85-95.","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1590\/S0482-50042010000100008","article-title":"Arrhythmias in systemic lupus erythematosus","volume":"50","author":"Teixeira","year":"2010","unstructured":"15. Teixeira RA, Borba EF, Bonf\u00e1 E, Martinelli Filho M. Arrhythmias in systemic lupus erythematosus. Rev Bras Reumatol 2010;50:81-9.","journal-title":"Rev Bras Reumatol"},{"key":"ref15","unstructured":"16. Guzm\u00e1n J, Cardiel MH, Arce-Salinas A, Alarc\u00f3n-Segovia D. The contribution of resting heart rate and routine blood tests to the clinical assessment of disease activity in systemic lupus erythematosus. J Rheumatol 1994;21:1845-8;"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0049-0172(87)90035-7","article-title":"Cardiovascular involvement in systemic lupus erythematosus","volume":"17","author":"Mandell","year":"1987","unstructured":"17. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987;17:126-41.","journal-title":"Semin Arthritis Rheum"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/acr.22370","article-title":"Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort","volume":"67","author":"Bourr\u00e9-Tessier","year":"2015","unstructured":"18. Bourr\u00e9-Tessier J, Urowitz MB, Clarke AE, et al. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care Res (Hoboken) 2015;67:128-35.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","article-title":"Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)","volume":"59","author":"Mavrogeni","year":"2020","unstructured":"19. Mavrogeni S, Gargani L, Pepe A, et al. Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS). Rheumatology (Oxford) 2020;59:1938-48.","journal-title":"Rheumatology (Oxford)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1002\/art.22971","article-title":"Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study","volume":"56","author":"Tzelepis","year":"2007","unstructured":"20. Tzelepis GE, Kelekis NL, Plastiras SC, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-36.","journal-title":"Arthritis Rheum"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-0736(96)80107-5","article-title":"Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis","volume":"29","author":"Rokas","year":"1996","unstructured":"21. Rokas S, Mavrikakis M, Agrios N, et al. Electrophysiologic abnormalities of cardiac function in progressive systemic sclerosis. J Electrocardiol 1996;29:17-25.","journal-title":"J Electrocardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1542-474X.2009.00306.x","article-title":"Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease","volume":"14","author":"Bie\u0142ous-Wilk","year":"2009","unstructured":"22. Bie\u0142ous-Wilk A, Poreba M, Staniszewska-Marsza\u0142ek E, et al. Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease. Ann Noninvasive Electrocardiol 2009;14:251-7.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Kostis JB, Seibold JR, Turkevich D, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988;84:1007-15. h","DOI":"10.1016\/0002-9343(88)90305-1"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/03009742.2011.609489","article-title":"Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation","volume":"41","author":"Borowiec","year":"2012","unstructured":"24. Borowiec A, Dabrowski R, Wozniak J, et al. Cardiovascular assessment of asymptomatic patients with juvenile-onset localized and systemic scleroderma: 10 years prospective observation. Scand J Rheumatol 2012;41:33-8.","journal-title":"Scand J Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/oxfordjournals.eurheartj.a061005","article-title":"24-h ECG monitoring in patients with rheumatoid arthritis","volume":"16","author":"T\u0142ustochowicz","year":"1995","unstructured":"25. T\u0142ustochowicz W, Piotrowicz R, Cwetsch A, et al. 24-h ECG monitoring in patients with rheumatoid arthritis. Eur Heart J 1995;16:848-51.","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s002960050079","article-title":"Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis","volume":"18","author":"Wis\u0142owska","year":"1999","unstructured":"26. Wis\u0142owska M, Sypu\u0142a S, Kowalik I. Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis. Rheumatol Int 1999;18:163-9.","journal-title":"Rheumatol Int"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Engelmann MD, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J2005;26:2083-92.","DOI":"10.1093\/eurheartj\/ehi350"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.jacc.2007.06.054","article-title":"Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data","volume":"50","author":"Issac","year":"2007","unstructured":"28. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007;50:2021-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jacc.2006.12.042","article-title":"Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis","volume":"49","author":"Liu","year":"2007","unstructured":"29. Liu T, Li G, Li L, Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00296-007-0307-8","article-title":"P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters","volume":"27","author":"Guler","year":"2007","unstructured":"30. Guler H, Seyfeli E, Sahin G, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 2007;27:813-8.","journal-title":"Rheumatol Int"},{"key":"ref30","unstructured":"31. Schwemmer S, Beer P, Sch\u00f6lmerich J, et al. Cardiovascular and pupillary autonomic nervous dysfunction in patients with rheumatoid arthritis - a cross-sectional and longitudinal study. Clin Exp Rheumatol 2006;24:683-9;"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015;12:e41-63.","DOI":"10.1016\/j.hrthm.2015.03.029"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","unstructured":"33. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977;56:255-86.","journal-title":"Medicine (Baltimore)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1001\/archinte.1984.04400020097015","article-title":"ECG abnormalities in polymyositis","volume":"144","author":"Stern","year":"1984","unstructured":"34. Stern R, Godbold JH, Chess Q, Kagen LJ. ECG abnormalities in polymyositis. Arch Intern Med 1984;144:2185-9.","journal-title":"Arch Intern Med"},{"key":"ref34","unstructured":"35. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996;14:373-9;"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/clc.4960161110","article-title":"The heart in polymyositis: a prospective evaluation of 26 patients","volume":"16","author":"Taylor","year":"1993","unstructured":"36. Taylor AJ, Wortham DC, Burge JR, Rogan KM. The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 1993;16:802-8.","journal-title":"Clin Cardiol"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Zhang L, Wang GC, Ma L, Zu N. Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 2012;35:686-91.","DOI":"10.1002\/clc.22026"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jccase.2017.06.003","article-title":"Focal right atrial tachycardia with three foci in a patient with polymyositis","volume":"16","author":"Yazaki","year":"2017","unstructured":"38. Yazaki K, Enta K, Kataoka S, et al. Focal right atrial tachycardia with three foci in a patient with polymyositis. J Cardiol Cases 2017;16:134-7.","journal-title":"J Cardiol Cases"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1191\/0961203305lu2205oa","article-title":"Cardiac involvement in autoimmune myositis and mixed connective tissue disease","volume":"14","author":"Lundberg","year":"2005","unstructured":"39. Lundberg IE. Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 2005;14:708-12.","journal-title":"Lupus"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.rdc.2013.10.006","article-title":"The heart in vasculitis","volume":"40","author":"Miloslavsky","year":"2014","unstructured":"40. Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am 2014;40:11-26.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","article-title":"Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients","volume":"44","author":"Gayraud","year":"2001","unstructured":"41. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.","journal-title":"Arthritis Rheum"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/qjmed\/hci015","article-title":"Primary systemic vasculitis: clinical features and mortality","volume":"98","author":"Lane","year":"2005","unstructured":"42. Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. QJM 2005;98:97-111.","journal-title":"QJM"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","article-title":"Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients","volume":"42","author":"Guillevin","year":"1999","unstructured":"43. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30.","journal-title":"Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","article-title":"Cardiac manifestations of systemic lupus erythematosus","volume":"40","author":"JJ","year":"2014","unstructured":"44. Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 2014;40:51-60.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00124743-199708000-00005","article-title":"Coronary artery disease in systemic lupus erythematosus: risk factors, assessment, and prevention","volume":"3","author":"Hashkes","year":"1997","unstructured":"45. Hashkes PJ, Wexler LF, Passo MH. Coronary artery disease in systemic lupus erythematosus: risk factors, assessment, and prevention. J Clin Rheumatol 1997;3:203-10.","journal-title":"J Clin Rheumatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1253\/circj.CJ-19-0705","article-title":"Cardiac arrhythmias in autoimmune diseases","volume":"84","author":"Gawa\u0142ko","year":"2020","unstructured":"46. Gawa\u0142ko M, Balsam P, Lodzi\u0144ski P, et al. Cardiac arrhythmias in autoimmune diseases. Circ J 2020;84:685-94.","journal-title":"Circ J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00296-011-2240-0","article-title":"Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus","volume":"33","author":"Huang","year":"2013","unstructured":"47. Huang CN, Yu HH, Chiu SN, et al. Acute myocarditis and ventricular fibrillation as initial presentation of pediatric systemic lupus erythematosus. Rheumatol Int 2013;33:1093-6.","journal-title":"Rheumatol Int"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00296-018-4110-5","article-title":"Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases","volume":"38","author":"Mavrogeni","year":"2018","unstructured":"48. Mavrogeni SI, Sfikakis PP, Dimitroulas T, et al. Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases. Rheumatol Int 2018;38:1615-21.","journal-title":"Rheumatol Int"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/art.20130","article-title":"Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA-positive connective tissue diseases","volume":"50","author":"Lazzerini","year":"2004","unstructured":"49. Lazzerini PE, Acampa M, Guideri F, et al. Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA-positive connective tissue diseases. Arthritis Rheum 2004;50:1248-52.","journal-title":"Arthritis Rheum"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/art.1780281110","article-title":"Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients","volume":"28","author":"Ferri","year":"1985","unstructured":"50. Ferri C, Bernini L, Bongiorni MG, et al. Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. Arthritis Rheum 1985;28:1259-66.","journal-title":"Arthritis Rheum"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"A cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","unstructured":"51. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53:483-90.","journal-title":"Circulation"},{"key":"ref51","unstructured":"52. Lee P, Langevitz P, Alderdice CA, et al. Mortality in systemic sclerosis (scleroderma). Q J Med 1992;82:139-48;"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/0002-8703(93)90075-K","article-title":"Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association","volume":"125","author":"Follansbee","year":"1993","unstructured":"53. Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993;125:194-203.","journal-title":"Am Heart J"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/sarh.2000.8367","article-title":"Giant cell myocarditis: most fatal of autoimmune diseases","volume":"30","author":"Rosenstein","year":"2000","unstructured":"54. Rosenstein ED, Zucker MJ, Kramer N. Giant cell myocarditis: most fatal of autoimmune diseases. Semin Arthritis Rheum 2000;30:1-16.","journal-title":"Semin Arthritis Rheum"},{"key":"ref54","unstructured":"55. Borek G, Jenzer HR, Frey LD, Locher JT. Repetitive exercise induced ventricular tachycardia in a patient with rheumatoid arthritis taking low dose methotrexate. J Rheumatol 1992;19:1004-5;"},{"key":"ref55","unstructured":"56. Lazzerini PE, Acampa M, Hammoud M, et al. Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, crossover study in patients with chronic arthritis. J Rheumatol 2008;35:1958-65;"},{"key":"ref56","unstructured":"57. Schwemmer S, Beer P, Sch\u00f6lmerich J, et al. Cardiovascular and pupillary autonomic nervous dysfunction in patients with rheumatoid arthritis - a cross-sectional and longitudinal study. Clin Exp Rheumatol 2006;24:683-9;"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"58. Jindal G, Singh S, Suri D, et al. Recurrent ventricular tachycardia in a child with juvenile dermatomyositis - an unusual association. Int J Rheum Dis 2012;15:e26-7.","DOI":"10.1111\/j.1756-185X.2012.01701.x"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.111.049882","article-title":"Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy","volume":"125","author":"Dilaveris","year":"2012","unstructured":"59. Dilaveris P, Pietri P, Tsiachris D, et al. Inducible ventricular tachycardia due to dermatomyositis-related cardiomyopathy in the era of implantable cardioverter-defibrillator therapy. Circulation 2012;125:967-9.","journal-title":"Circulation"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/heart.88.5.443","article-title":"Ventricular tachycardia as a presenting feature of dermatomyositis","volume":"88","author":"Adler","year":"2002","unstructured":"60. Adler M, Banerjeee S, Stratton R. Ventricular tachycardia as a presenting feature of dermatomyositis. Heart 2002;88:443.","journal-title":"Heart"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.7326\/0003-4819-63-3-402","article-title":"Pathology of the cardiac conduction system in systemic lupus erythematosus","volume":"63","author":"James","year":"1965","unstructured":"61. James TN, Rupe CE, Monto RW. Pathology of the cardiac conduction system in systemic lupus erythematosus. Ann Intern Med 1965;63:402-10.","journal-title":"Ann Intern Med"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1053\/euhj.2000.2186","article-title":"Immunological basis of the cardiac conduction and rhythm disorders","volume":"22","author":"Maisch","year":"2001","unstructured":"62. Maisch B, Risti\u0107 AD. Immunological basis of the cardiac conduction and rhythm disorders. Eur Heart J 2001;22:813-24.","journal-title":"Eur Heart J"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1161\/01.CIR.103.11.1599","article-title":"Direct inhibition of expressed cardiac l- and T-type calcium channels by IGG from mothers whose children have congenital heart block","volume":"103","author":"Xiao","year":"2001","unstructured":"63. Xiao GQ, Hu K, Boutjdir M. Direct inhibition of expressed cardiac l- and T-type calcium channels by IGG from mothers whose children have congenital heart block. Circulation 2001;103:1599-604.","journal-title":"Circulation"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1191\/0961203305lu2225oa","article-title":"QT-interval parameters are increased in systemic lupus erythematosus patients","volume":"14","author":"Cardoso","year":"2005","unstructured":"64. Cardoso CR, Sales MA, Papi JA, Salles GF. QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 2005;14:846-52.","journal-title":"Lupus"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/acr.20470","article-title":"Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus","volume":"63","author":"Bourr\u00e9-Tessier","year":"2011","unstructured":"65. Bourr\u00e9-Tessier J, Clarke AE, Huynh T, et al. Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011;63:1031-7.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.7326\/0003-4819-94-1-38","article-title":"The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis","volume":"94","author":"Roberts","year":"1981","unstructured":"66. Roberts NK, Cabeen WR Jr, Moss J, et al. The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med 1981;94:38-40.","journal-title":"Ann Intern Med"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0049-0172(89)90032-2","article-title":"Heart disease in systemic sclerosis","volume":"19","author":"Janosik","year":"1989","unstructured":"67. Janosik DL, Osborn TG, Moore TL, et al. Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989;19:191-200.","journal-title":"Semin Arthritis Rheum"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0002-9343(76)90373-9","article-title":"Clinical and pathologic features of 35 patients","volume":"61","author":"Ridolfi","year":"1976","unstructured":"68. Ridolfi RL, Bulkley BH, Hutchins GM. The cardiac conduction system in progressive systemic sclerosis. Clinical and pathologic features of 35 patients. Am J Med 1976;61:361-6.","journal-title":"Am J Med"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/ard.42.4.389","article-title":"Complete heart block in rheumatoid arthritis","volume":"42","author":"Ahern","year":"1983","unstructured":"69. Ahern M, Lever JV, Cosh J. Complete heart block in rheumatoid arthritis. Ann Rheum Dis 1983;42:389-97.","journal-title":"Ann Rheum Dis"},{"key":"ref69","unstructured":"70. Wallberg-Jonsson S, Ohman ML, Dahlqvist SR. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 1997;24:445-51;"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","article-title":"Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis","volume":"107","author":"Solomon","year":"2003","unstructured":"71. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.","journal-title":"Circulation"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/000331970305400615","article-title":"Polymyositis complicated with complete atrioventricular block - a case report and review of the literature","volume":"54","author":"Alyan","year":"2003","unstructured":"72. Alyan O, Ozdemir O, Geyik B, Demirkan D. Polymyositis complicated with complete atrioventricular block - a case report and review of the literature. Angiology 2003;54:729-31.","journal-title":"Angiology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/clc.4960160319","article-title":"Polymorphism of the cardiac manifestations in dermatomyositis","volume":"16","author":"LF","year":"1993","unstructured":"73. Tami LF, Bhasin S. Polymorphism of the cardiac manifestations in dermatomyositis. Clin Cardiol 1993;16:260-4.","journal-title":"Clin Cardiol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-94-1-41","article-title":"Cardiac conduction defects in polymyositis: electrophysiologic studies in four patients","volume":"94","author":"Kehoe","year":"1981","unstructured":"74. Kehoe RF, Bauernfeind R, Tommaso C, et al. Cardiac conduction defects in polymyositis: electrophysiologic studies in four patients. Ann Intern Med 1981;94:41-3.","journal-title":"Ann Intern Med"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/BOR.0b013e32831cb94d","article-title":"Involvement of the heart by small and medium vessel vasculitis","volume":"21","author":"GC","year":"2009","unstructured":"75. Kane GC, Keogh KA. Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol 2009;21:29-34.","journal-title":"Curr Opin Rheumatol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/ard.2004.029033","article-title":"Accelerated atherosclerosis in patients with Wegener's granulomatosis","volume":"64","author":"de Leeuw","year":"2005","unstructured":"76. de Leeuw K, Sanders JS, Stegeman C, et al. Accelerated atherosclerosis in patients with Wegener's granulomatosis. Ann Rheum Dis 2005;64:753-9.","journal-title":"Ann Rheum Dis"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","unstructured":"77. Faurschou M, Mellemkjaer L, Sorensen IJ, et al. Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis. Arthritis Rheum 2009;60:1187-92.","journal-title":"Arthritis Rheum"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"78. England BR, Thiele GM, Anderson DR, Mikuls TR. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ 2018;361:k1036.","DOI":"10.1136\/bmj.k1036"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79. Ocampo-Piraquive V, Nieto-Aristiz\u00e1bal I, Ca\u00f1as CA, Tob\u00f3n GJ. Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol2018;14:1043-53.","DOI":"10.1080\/1744666X.2018.1538789"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.semarthrit.2006.10.004","article-title":"Determinants of pulmonary arterial hypertension in scleroderma","volume":"36","author":"Plastiras","year":"2007","unstructured":"80. Plastiras SC, Karadimitrakis SP, Kampolis C, et al. Determinants of pulmonary arterial hypertension in scleroderma. Semin Arthritis Rheum 2007;36:392-6.","journal-title":"Semin Arthritis Rheum"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","unstructured":"81. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.","journal-title":"Ann Rheum Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","unstructured":"82. Elhai M, Meune C, Boubaya M, et al. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 2017;76:1897-905.","journal-title":"Ann Rheum Dis"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83. Gabriel SE. Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 2008;121:S9-14.","DOI":"10.1016\/j.amjmed.2008.06.011"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/CRD.0000000000000241","article-title":"Cardiac manifestations in idiopathic inflammatory myopathies: an overview","volume":"27","author":"Jayakumar","year":"2019","unstructured":"84. Jayakumar D, Zhang R, Wasserman A, Ash J. Cardiac manifestations in idiopathic inflammatory myopathies: an overview. Cardiol Rev 2019;27:131-7.","journal-title":"Cardiol Rev"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.autrev.2014.01.052","article-title":"Unmet needs in the treatment of autoimmunity: from aspirin to stem cells","volume":"13","author":"Chang","year":"2014","unstructured":"85. Chang C. Unmet needs in the treatment of autoimmunity: from aspirin to stem cells. Autoimmun Rev 2014;13:331-46.","journal-title":"Autoimmun Rev"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12016-008-8114-x","article-title":"Recent advances in the treatment of systemic sclerosis","volume":"36","author":"Bournia","year":"2009","unstructured":"86. Bournia VK, Vlachoyiannopoulos PG, Selmi C, et al. Recent advances in the treatment of systemic sclerosis. Clin Rev Allergy Immunol 2009;36:176-200.","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","unstructured":"87. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018;72:3158-76.","journal-title":"J Am Coll Cardiol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/BOR.0b013e32834b8975","article-title":"Systemic sclerosis and the heart: current diagnosis and management","volume":"23","author":"Desai","year":"2011","unstructured":"88. Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol 2011;23:545-54.","journal-title":"Curr Opin Rheumatol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/ard.2008.103382","article-title":"Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis","volume":"69","author":"Allanore","year":"2010","unstructured":"89. Allanore Y, Meune C, Vonk MC, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010;69:218-221.","journal-title":"Ann Rheum Dis"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/europace\/euw301","article-title":"European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias","volume":"19","author":"Katritsis","year":"2017","unstructured":"90. Katritsis DG, Boriani G, Cosio FG, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias. Europace 2017;19:465-511.","journal-title":"Europace"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"91. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Heart Rhythm 2018;15:e190-252.","DOI":"10.1016\/j.hrthm.2017.10.035"},{"key":"ref91","unstructured":"92. Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace 2015;17:1601-87."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/europace\/eus081","article-title":"Surgical ablation for atrial fibrillation","volume":"14","author":"Fragakis","year":"2012","unstructured":"93. Fragakis N, Pantos I, Younis J, et al. Surgical ablation for atrial fibrillation. Europace 2012;14:1545-52.","journal-title":"Europace"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2010.03.016","article-title":"Catheter ablation of atrial fibrillation the search for substrate-driven end points","volume":"55","author":"Katritsis","year":"2010","unstructured":"94. Katritsis D, Merchant FM, Mela T, et al. Catheter ablation of atrial fibrillation the search for substrate-driven end points. J Am Coll Cardiol 2010;55:2293-8.","journal-title":"J Am Coll Cardiol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"130","DOI":"10.15420\/AER.2016.18.2","article-title":"Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia","volume":"5","author":"DG","year":"2016","unstructured":"95. Katritsis DG, Josephson ME. Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia. Arrhythm Electrophysiol Rev 2016;5:130-5.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15420\/aer.2012.1.29","article-title":"Catheter ablation of atrial fibrillation - techniques and technology","volume":"1","author":"Katritsis","year":"2012","unstructured":"96. Katritsis G, Calkins H. Catheter ablation of atrial fibrillation - techniques and technology. Arrhythm Electrophysiol Rev 2012;1:29-33.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15420\/aer.2019.9.2","article-title":"The evolving role of catheter ablation in patients with heart failure and AF","volume":"8","author":"Prabhu","year":"2019","unstructured":"97. Prabhu S, Lim WH, Schilling RJ. The evolving role of catheter ablation in patients with heart failure and AF. Arrhythm Electrophysiol Rev 2019;8:47-53.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15420\/aer.2014.3.2.107","article-title":"New ablation technologies and techniques","volume":"3","author":"Mahida","year":"2014","unstructured":"98. Mahida S, Berte B, Yamashita S, et al. New ablation technologies and techniques. Arrhythm Electrophysiol Rev 2014;3:107-12.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15420\/aer.2014.3.2.113","article-title":"Cardiac autonomic denervation for ablation of atrial fibrillation","volume":"3","author":"GD","year":"2014","unstructured":"99. Katritsis GD, Katritsis DG. Cardiac autonomic denervation for ablation of atrial fibrillation. Arrhythm Electrophysiol Rev 2014;3:113-5.","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10840-012-9672-7","article-title":"2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"33","author":"Calkins","year":"2012","unstructured":"100. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012;33:171-257.","journal-title":"J Interv Card Electrophysiol"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1161\/CIRCULATIONAHA.108.848218","article-title":"Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis","volume":"119","author":"KM","year":"2009","unstructured":"101. Ho KM, Tan JA. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis. Circulation 2009;119:1853-66.","journal-title":"Circulation"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"102. Schmidt M, Christiansen CF, Mehnert F, et al. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study. BMJ 2011;343:d3450.","DOI":"10.1136\/bmj.d3450"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.hjc.2016.10.006","article-title":"Usefulness of cardiovascular magnetic resonance imaging in supraventricular tachycardia ablation in a scleroderma patient","volume":"58","author":"Chatzidou","year":"2017","unstructured":"103. Chatzidou S, Repasos V, Palios J, Plastiras S. Usefulness of cardiovascular magnetic resonance imaging in supraventricular tachycardia ablation in a scleroderma patient. Hellenic J Cardiol 2017;58:159-60.","journal-title":"Hellenic J Cardiol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.eupc.2004.03.012","article-title":"Electroanatomic mapping and ablation of ventricular tachycardia associated with systemic sclerosis","volume":"6","author":"Lacroix","year":"2004","unstructured":"104. Lacroix D, Brigadeau F, Marqui\u00e9 C, Klug D. Electroanatomic mapping and ablation of ventricular tachycardia associated with systemic sclerosis. Europace 2004;6:336-42.","journal-title":"Europace"},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"105. Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur Heart J 2017;38:1717-27.","DOI":"10.1093\/eurheartj\/ehw208"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1517\/14656566.2015.1100170","article-title":"Advances in the pharmacologic treatment of ventricular arrhythmias","volume":"16","author":"Schleifer","year":"2015","unstructured":"106. Schleifer JW, Sorajja D, Shen WK. Advances in the pharmacologic treatment of ventricular arrhythmias. Expert Opin Pharmacother 2015;16:2637-2651.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2020.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T16:29:48Z","timestamp":1620232188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2020.43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,12]]},"published-print":{"date-parts":[[2021,4,12]]}},"alternative-id":["aer.2020.43"],"URL":"https:\/\/doi.org\/10.15420\/aer.2020.43","relation":{},"ISSN":["2050-3369","2050-3377"],"issn-type":[{"value":"2050-3369","type":"print"},{"value":"2050-3377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]}}}